Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-Sep 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2037361000001112 | Spikevax | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2037371000001119 | Spikevax (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Spikevax | Is a | Trade family | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Spikevax COVID-19 mRNA (nucleoside modified) Vaccine 0.1mg/0.5ml dose dispersion for injection multidose vials (Moderna, Inc) | Is a | True | Spikevax | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR